Index RUT
P/E -
EPS (ttm) -0.52
Insider Own 3.01%
Shs Outstand 293.59M
Perf Week 0.30%
Market Cap 3.46B
Forward P/E 29.57
EPS next Y 0.40
Insider Trans -5.67%
Shs Float 286.50M
Perf Month -9.46%
Income -151.58M
PEG -
EPS next Q -0.06
Inst Own 106.62%
Short Float 11.31%
Perf Quarter -18.75%
Sales 399.36M
P/S 8.67
EPS this Y 100.97%
Inst Trans -4.34%
Short Ratio 10.34
Perf Half Y -8.97%
Book/sh 0.55
P/B 21.49
EPS next Y 7948.83%
ROA -20.18%
Short Interest 32.40M
Perf Year 4.59%
Cash/sh 0.97
P/C 12.10
EPS next 5Y -
ROE -107.04%
52W Range 9.70 - 14.57
Perf YTD -17.37%
Dividend Est. -
P/FCF -
EPS past 5Y 22.84%
ROI -25.39%
52W High -19.53%
Beta 0.75
Dividend TTM -
Quick Ratio 2.52
Sales past 5Y 37.81%
Gross Margin 88.68%
52W Low 20.87%
ATR (14) 0.46
Dividend Ex-Date -
Current Ratio 2.88
EPS Y/Y TTM 37.05%
Oper. Margin -18.40%
RSI (14) 42.11
Volatility 3.68% 4.26%
Employees 517
Debt/Eq 2.78
Sales Y/Y TTM 21.30%
Profit Margin -37.96%
Recom 1.55
Target Price 19.00
Option/Short Yes / Yes
LT Debt/Eq 2.73
EPS Q/Q 41.97%
Payout -
Rel Volume 0.41
Prev Close 11.86
Sales Surprise 0.64%
EPS Surprise -90.31%
Sales Q/Q 30.63%
Earnings Feb 28 BMO
Avg Volume 3.13M
Price 11.72
SMA20 -3.23%
SMA50 -7.40%
SMA200 -5.22%
Trades
Volume 868,323
Change -1.14%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-19-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$15 → $20
Sep-09-22 Initiated
Morgan Stanley
Equal-Weight
$14
Apr-13-22 Resumed
Goldman
Neutral
$11
Jan-14-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$12 → $16
Nov-15-21 Upgrade
Stifel
Hold → Buy
$12 → $16
Sep-30-21 Upgrade
JP Morgan
Neutral → Overweight
$16
Jul-19-21 Resumed
BTIG Research
Buy
$15
May-27-21 Initiated
Needham
Hold
May-21-21 Initiated
UBS
Buy
$16
Apr-14-21 Upgrade
Cantor Fitzgerald
Neutral → Overweight
$17
Mar-02-21 Initiated
Stifel
Hold
$13
Feb-12-21 Downgrade
JP Morgan
Overweight → Neutral
$19
Feb-12-21 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$30 → $17
Dec-28-20 Resumed
Cantor Fitzgerald
Overweight
$20 → $30
Dec-10-20 Downgrade
Citigroup
Buy → Neutral
$20 → $27
Nov-11-20 Initiated
Berenberg
Hold
Jun-17-20 Initiated
BTIG Research
Buy
$19
Feb-04-20 Resumed
Cantor Fitzgerald
Overweight
$19 → $20
Nov-12-19 Reiterated
H.C. Wainwright
Buy
$18 → $20
Jun-17-19 Initiated
H.C. Wainwright
Buy
$18
Show Previous Ratings
Mar-26-24 09:53AM
Mar-20-24 07:00AM
Mar-13-24 07:07AM
Mar-06-24 11:56PM
Mar-05-24 01:50PM
(Investor's Business Daily)
07:00AM
Loading…
Mar-01-24 07:00AM
Feb-29-24 11:25AM
11:23AM
Feb-28-24 11:49PM
(Thomson Reuters StreetEvents) -6.50%
08:20AM
07:32AM
07:00AM
Feb-15-24 07:00AM
Feb-09-24 03:14PM
(Investor's Business Daily)
Feb-08-24 07:00AM
07:00AM
Loading…
Feb-01-24 07:00AM
Jan-12-24 11:02PM
09:31AM
Jan-08-24 09:40AM
Jan-07-24 04:00PM
Jan-05-24 07:02PM
Jan-03-24 11:46AM
07:00AM
Dec-30-23 09:01AM
Dec-29-23 09:48AM
07:01AM
Dec-24-23 06:17AM
Dec-21-23 05:01AM
Dec-08-23 11:30AM
Dec-05-23 06:38AM
06:00AM
Loading…
06:00AM
05:30AM
(The Wall Street Journal)
Nov-15-23 09:48AM
Nov-10-23 10:07AM
Nov-09-23 01:02PM
Nov-08-23 07:13AM
(Associated Press Finance)
07:00AM
Nov-04-23 05:03AM
Nov-02-23 10:00AM
Nov-01-23 10:01AM
07:00AM
Oct-27-23 07:00AM
Oct-08-23 07:00AM
Oct-05-23 07:45PM
03:01AM
Oct-03-23 07:00AM
Oct-02-23 08:20AM
Oct-01-23 08:30PM
Sep-29-23 12:22PM
(Associated Press Finance)
09:09AM
Sep-28-23 11:08AM
10:50AM
10:41AM
10:32AM
(Investor's Business Daily)
Sep-21-23 08:42AM
Sep-07-23 11:30AM
Sep-01-23 07:00AM
Aug-29-23 07:00AM
Aug-21-23 07:00AM
Aug-15-23 07:00AM
Aug-09-23 09:25AM
Aug-08-23 08:40AM
07:29AM
07:00AM
Aug-07-23 08:48AM
Aug-04-23 08:05AM
Jul-31-23 07:00AM
Jul-23-23 10:23AM
Jul-20-23 02:24PM
(Investor's Business Daily)
Jul-17-23 01:54PM
(Investor's Business Daily)
Jun-28-23 10:53AM
Jun-27-23 07:00AM
Jun-09-23 11:30AM
Jun-04-23 09:59AM
May-11-23 07:44AM
May-10-23 08:15AM
07:10AM
07:00AM
May-08-23 10:00AM
May-02-23 07:00AM
May-01-23 10:01AM
07:00AM
Apr-26-23 01:00PM
Apr-18-23 09:20AM
Apr-14-23 02:45PM
Mar-31-23 11:30AM
Mar-27-23 07:00AM
Mar-08-23 07:00AM
Mar-02-23 11:39AM
04:28AM
(Thomson Reuters StreetEvents)
Mar-01-23 09:35AM
07:00AM
Feb-27-23 07:00AM
Feb-22-23 05:00PM
Feb-14-23 07:00AM
Feb-13-23 07:00AM
Feb-12-23 07:33AM
Feb-08-23 07:00AM
Feb-01-23 09:43AM
Jan-09-23 07:00AM
Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SBLENDORIO GLENN Director Mar 07 '24 Option Exercise 2.80 15,000 42,000 83,596 Mar 11 05:36 PM RAAB MICHAEL Director Mar 05 '24 Option Exercise 2.80 15,000 42,000 83,596 Mar 06 05:22 PM MCGLYNN MARGARET G Director Mar 05 '24 Option Exercise 2.80 7,500 21,000 66,789 Mar 06 05:21 PM MCGLYNN MARGARET G Director Mar 05 '24 Sale 13.40 7,500 100,500 59,289 Mar 06 05:21 PM MCGLYNN MARGARET G Director Mar 04 '24 Option Exercise 2.80 7,500 21,000 66,789 Mar 06 05:21 PM MCGLYNN MARGARET G Director Mar 04 '24 Sale 13.29 7,500 99,675 59,289 Mar 06 05:21 PM Campbell Bradley L President and CEO Mar 01 '24 Option Exercise 10.54 15,833 166,904 887,052 Mar 05 05:14 PM Crowley John F Executive Chairman Mar 01 '24 Sale 13.35 29,181 389,543 573,478 Mar 05 05:14 PM Campbell Bradley L President and CEO Mar 01 '24 Sale 13.14 15,833 208,017 871,219 Mar 05 05:14 PM Crowley John F Executive Chairman Feb 15 '24 Sale 13.81 31,614 436,551 697,628 Feb 20 05:23 PM Clark David Michael Chief People Officer Feb 15 '24 Sale 14.00 4,427 61,978 253,664 Feb 20 05:20 PM Campbell Bradley L President and CEO Feb 15 '24 Sale 14.00 4,167 58,338 871,219 Feb 20 05:21 PM Rosenberg Ellen Chief Legal Officer Feb 07 '24 Option Exercise 5.16 29,600 152,736 397,254 Feb 08 04:40 PM Rosenberg Ellen Chief Legal Officer Feb 07 '24 Sale 13.00 29,600 384,818 367,654 Feb 08 04:40 PM Rosenberg Ellen Chief Legal Officer Feb 06 '24 Option Exercise 5.16 400 2,064 368,054 Feb 08 04:40 PM Rosenberg Ellen Chief Legal Officer Feb 06 '24 Sale 13.00 400 5,200 367,654 Feb 08 04:40 PM Campbell Bradley L President and CEO Feb 01 '24 Option Exercise 10.54 15,833 166,904 891,219 Feb 05 07:22 PM Crowley John F Executive Chairman Feb 01 '24 Sale 12.62 31,614 398,918 750,838 Feb 05 07:22 PM Campbell Bradley L President and CEO Feb 01 '24 Sale 12.56 15,833 198,858 875,386 Feb 05 07:22 PM Crowley John F Executive Chairman Jan 22 '24 Sale 12.36 55,327 683,958 782,452 Jan 24 05:20 PM Crowley John F Executive Chairman Jan 16 '24 Sale 12.78 31,614 404,106 837,779 Jan 18 05:09 PM Crowley John F Executive Chairman Jan 10 '24 Sale 13.65 31,614 431,452 869,393 Jan 11 06:33 PM Clark David Michael Chief People Officer Jan 09 '24 Sale 14.00 1,384 19,376 266,705 Jan 09 06:08 PM Prout Samantha Chief Accounting Officer Jan 09 '24 Sale 14.00 1,337 18,718 80,953 Jan 09 06:07 PM Prout Samantha Chief Accounting Officer Jan 08 '24 Sale 14.00 30,767 430,827 82,290 Jan 09 06:07 PM Clark David Michael Chief People Officer Jan 08 '24 Sale 14.00 8,726 122,164 268,089 Jan 09 06:08 PM Campbell Bradley L President and CEO Jan 02 '24 Option Exercise 10.54 15,833 166,904 956,138 Jan 04 06:35 PM Rosenberg Ellen Chief Legal Officer Jan 02 '24 Option Exercise 5.16 30,000 154,800 372,285 Jan 04 06:24 PM Rosenberg Ellen Chief Legal Officer Jan 02 '24 Sale 14.21 30,000 426,219 342,285 Jan 04 06:24 PM Campbell Bradley L President and CEO Jan 02 '24 Sale 14.23 15,833 225,380 947,805 Jan 04 06:35 PM Castelli Jeff Chief Development Officer Dec 28 '23 Sale 14.52 17,421 252,902 340,661 Dec 29 05:18 PM Rosenberg Ellen Chief Legal Officer Dec 27 '23 Option Exercise 5.16 5,000 25,800 347,285 Dec 28 05:08 PM Rosenberg Ellen Chief Legal Officer Dec 27 '23 Sale 14.07 5,000 70,327 342,285 Dec 28 05:08 PM Rosenberg Ellen Chief Legal Officer Dec 26 '23 Option Exercise 5.16 30,000 154,800 372,285 Dec 28 05:08 PM Rosenberg Ellen Chief Legal Officer Dec 26 '23 Sale 14.00 30,000 420,084 342,285 Dec 28 05:08 PM Prout Samantha Chief Accounting Officer Dec 26 '23 Sale 14.00 7,659 107,228 121,912 Dec 28 05:09 PM Castelli Jeff Chief Development Officer Dec 20 '23 Sale 13.10 1,654 21,667 358,082 Dec 20 04:41 PM Castelli Jeff Chief Development Officer Dec 19 '23 Sale 13.25 17,500 231,875 359,736 Dec 20 04:41 PM Crowley John F Executive Chairman Dec 15 '23 Sale 12.66 6,043 76,516 877,748 Dec 19 05:55 PM Campbell Bradley L President and CEO Dec 01 '23 Option Exercise 2.94 11,702 34,404 803,863 Dec 05 05:07 PM Campbell Bradley L President and CEO Dec 01 '23 Sale 11.08 11,702 129,693 792,161 Dec 05 05:07 PM Crowley John F Executive Chairman Dec 01 '23 Sale 11.08 6,043 66,956 883,791 Dec 05 05:03 PM Crowley John F Executive Chairman Nov 15 '23 Sale 10.84 6,043 65,497 889,834 Nov 17 05:23 PM Campbell Bradley L President and CEO Nov 01 '23 Option Exercise 2.94 11,700 34,398 803,861 Nov 03 07:38 PM Campbell Bradley L President and CEO Nov 01 '23 Sale 10.97 11,700 128,391 792,161 Nov 03 07:38 PM Crowley John F Executive Chairman Nov 01 '23 Sale 10.97 6,044 66,327 895,877 Nov 03 07:37 PM Crowley John F Executive Chairman Oct 16 '23 Sale 10.50 6,044 63,449 901,921 Oct 18 07:57 PM Campbell Bradley L President & CEO Oct 02 '23 Option Exercise 2.94 11,700 34,398 803,861 Oct 04 06:57 PM Campbell Bradley L President & CEO Oct 02 '23 Sale 11.24 11,700 131,489 792,161 Oct 04 06:57 PM Crowley John F Executive Chairman Oct 02 '23 Sale 11.25 6,044 67,967 907,965 Oct 04 06:58 PM Crowley John F Executive Chairman Sep 15 '23 Sale 13.06 6,044 78,964 914,009 Sep 18 05:09 PM Campbell Bradley L President & CEO Sep 01 '23 Option Exercise 2.94 11,700 34,398 810,254 Sep 06 05:29 PM Campbell Bradley L President & CEO Sep 01 '23 Sale 12.97 18,093 234,648 792,161 Sep 06 05:29 PM Crowley John F Executive Chairman Sep 01 '23 Sale 12.98 6,044 78,447 920,053 Sep 06 05:31 PM Crowley John F Executive Chairman Aug 15 '23 Sale 13.03 6,044 78,734 926,097 Aug 16 05:33 PM Prout Samantha Chief Accounting Officer Aug 09 '23 Option Exercise 11.03 36,909 407,116 173,912 Aug 11 05:28 PM Prout Samantha Chief Accounting Officer Aug 09 '23 Sale 14.01 36,909 516,933 137,003 Aug 11 05:28 PM Campbell Bradley L President & CEO Aug 01 '23 Option Exercise 2.94 11,700 34,398 818,554 Aug 03 05:09 PM Campbell Bradley L President & CEO Aug 01 '23 Sale 13.39 20,000 267,874 798,554 Aug 03 05:09 PM Crowley John F Executive Chairman Aug 01 '23 Sale 13.35 6,044 80,716 932,141 Aug 03 05:10 PM Crowley John F Executive Chairman Jul 17 '23 Sale 13.45 6,044 81,263 938,185 Jul 19 05:45 PM Campbell Bradley L President & CEO Jul 13 '23 Sale 12.51 6,800 85,091 806,854 Jul 14 05:06 PM Campbell Bradley L President & CEO Jul 12 '23 Sale 12.51 1,500 18,759 813,654 Jul 14 05:06 PM Campbell Bradley L President & CEO Jul 03 '23 Option Exercise 2.94 11,700 34,398 826,854 Jul 06 06:25 PM Campbell Bradley L President & CEO Jul 03 '23 Sale 12.31 11,700 144,016 815,154 Jul 06 06:25 PM Crowley John F Executive Chairman Jul 03 '23 Sale 12.31 6,044 74,406 944,229 Jul 06 06:26 PM Crowley John F Executive Chairman Jun 15 '23 Sale 13.04 6,044 78,814 950,273 Jun 20 05:18 PM Campbell Bradley L President & CEO Jun 06 '23 Sale 12.50 8,300 103,777 815,154 Jun 08 05:26 PM Campbell Bradley L President & CEO Jun 01 '23 Option Exercise 2.64 11,700 30,907 835,154 Jun 05 07:16 PM Campbell Bradley L President & CEO Jun 01 '23 Sale 11.36 11,700 132,942 823,454 Jun 05 07:16 PM Crowley John F Executive Chairman Jun 01 '23 Sale 11.36 6,044 68,657 956,317 Jun 05 07:16 PM SBLENDORIO GLENN Director May 18 '23 Option Exercise 3.32 15,000 49,800 86,719 May 19 05:13 PM Crowley John F Executive Chairman May 15 '23 Sale 11.18 6,044 67,577 962,361 May 17 06:20 PM Campbell Bradley L President & CEO May 01 '23 Option Exercise 2.45 11,700 28,665 835,154 May 03 04:31 PM Campbell Bradley L President & CEO May 01 '23 Sale 11.80 11,700 138,093 823,454 May 03 04:31 PM Crowley John F Executive Chairman May 01 '23 Sale 11.80 6,044 71,335 968,405 May 03 04:35 PM Crowley John F Executive Chairman Apr 17 '23 Sale 11.66 6,044 70,502 974,449 Apr 19 05:45 PM Campbell Bradley L President & CEO Apr 03 '23 Option Exercise 2.45 11,700 28,665 835,154 Apr 05 08:25 PM Campbell Bradley L President & CEO Apr 03 '23 Sale 11.21 11,700 131,207 823,454 Apr 05 08:25 PM Crowley John F Executive Chairman Apr 03 '23 Sale 11.22 6,044 67,787 980,493 Apr 05 08:26 PM
Index -
P/E 62.56
EPS (ttm) 5.58
Insider Own 18.85%
Shs Outstand 22.05M
Perf Week 12.10%
Market Cap 6.36B
Forward P/E 23.51
EPS next Y 14.85
Insider Trans -2.46%
Shs Float 14.79M
Perf Month 32.03%
Income 127.56M
PEG 250.25
EPS next Q -0.15
Inst Own 90.49%
Short Float 12.29%
Perf Quarter 16.60%
Sales 3.03B
P/S 2.10
EPS this Y 31.15%
Inst Trans 1.19%
Short Ratio 3.36
Perf Half Y 35.97%
Book/sh -9.63
P/B -
EPS next Y 64.77%
ROA 2.70%
Short Interest 1.82M
Perf Year 44.65%
Cash/sh 6.79
P/C 51.41
EPS next 5Y 0.25%
ROE 52.36%
52W Range 207.26 - 406.38
Perf YTD 19.75%
Dividend Est. -
P/FCF -
EPS past 5Y 2.93%
ROI 3.92%
52W High -14.11%
Beta 2.44
Dividend TTM -
Quick Ratio 0.40
Sales past 5Y 10.18%
Gross Margin 45.86%
52W Low 68.40%
ATR (14) 16.21
Dividend Ex-Date -
Current Ratio 1.26
EPS Y/Y TTM -59.77%
Oper. Margin 14.13%
RSI (14) 71.94
Volatility 5.81% 4.22%
Employees 6180
Debt/Eq -
Sales Y/Y TTM -15.63%
Profit Margin 4.21%
Recom 2.29
Target Price 333.80
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q -86.45%
Payout 0.00%
Rel Volume 9.25
Prev Close 296.99
Sales Surprise -5.05%
EPS Surprise -56.80%
Sales Q/Q -4.43%
Earnings Mar 27 AMC
Avg Volume 540.95K
Price 349.04
SMA20 22.56%
SMA50 28.60%
SMA200 19.20%
Trades
Volume 3,345,991
Change 17.52%
Date
Action
Analyst
Rating Change
Price Target Change
Today Reiterated
Telsey Advisory Group
Market Perform
$285 → $335
Dec-08-23 Reiterated
Telsey Advisory Group
Market Perform
$325 → $285
Dec-05-23 Reiterated
Telsey Advisory Group
Market Perform
$365 → $325
Jun-29-23 Downgrade
Loop Capital
Buy → Hold
$300
Mar-06-23 Downgrade
Jefferies
Buy → Hold
$298
Feb-06-23 Downgrade
Telsey Advisory Group
Outperform → Market Perform
$330
Feb-06-23 Downgrade
Telsey Advisory Group
Outperform → Market Perform
$310 → $330
Dec-12-22 Downgrade
Goldman
Neutral → Sell
$227 → $215
Dec-09-22 Reiterated
Telsey Advisory Group
Outperform
$315 → $310
Nov-21-22 Downgrade
Barclays
Overweight → Equal Weight
$328 → $243
Nov-18-22 Downgrade
Wedbush
Outperform → Neutral
$274 → $270
Sep-21-22 Resumed
William Blair
Outperform
$28 → $21
Jun-30-22 Reiterated
Telsey Advisory Group
Outperform
$375 → $285
May-16-22 Initiated
Morgan Stanley
Equal-Weight
$400
Mar-30-22 Upgrade
Jefferies
Hold → Buy
$634 → $560
Jun-10-21 Upgrade
Gordon Haskett
Hold → Accumulate
Mar-26-21 Upgrade
Jefferies
Underperform → Hold
$335 → $500
Mar-25-21 Reiterated
Telsey Advisory Group
Outperform
$550 → $600
Mar-09-21 Initiated
Citigroup
Buy
$560
Jan-19-21 Reiterated
Guggenheim
Buy
$525 → $650
Show Previous Ratings
Today 12:36PM
11:40AM
10:47AM
(The Wall Street Journal)
10:07AM
07:30AM
07:29AM
Loading…
07:29AM
Mar-27-24 10:33PM
09:53PM
05:35PM
05:35PM
05:29PM
04:35PM
04:18PM
04:05PM
Mar-26-24 03:00AM
09:15AM
Loading…
Mar-25-24 09:15AM
Mar-22-24 06:45AM
Mar-21-24 03:00AM
Mar-17-24 07:00AM
Mar-04-24 12:20PM
09:35AM
Feb-13-24 12:10PM
Feb-05-24 04:32PM
Feb-01-24 04:30AM
Jan-24-24 04:41PM
Jan-19-24 12:41AM
Jan-18-24 08:32AM
Dec-23-23 09:01AM
Dec-19-23 09:17PM
04:00AM
04:21PM
Loading…
Dec-18-23 04:21PM
(Nation's Restaurant News)
Dec-13-23 06:44PM
(Morningstar Research) +12.15%
Dec-11-23 04:15PM
10:53AM
Dec-08-23 06:49PM
(Morningstar Research) -14.00%
01:36PM
01:10PM
12:21PM
12:09PM
11:53AM
11:48AM
09:06AM
Dec-07-23 09:54PM
07:08PM
05:51PM
04:41PM
04:05PM
Dec-06-23 02:01AM
Nov-30-23 04:05PM
Nov-22-23 06:34PM
Nov-20-23 06:41PM
09:17AM
Nov-15-23 08:25AM
Nov-14-23 01:15PM
12:10PM
Nov-07-23 07:35AM
Nov-05-23 08:00AM
(The Wall Street Journal)
Oct-20-23 10:50AM
Oct-18-23 05:03PM
09:26AM
Oct-17-23 05:51PM
Oct-16-23 04:43PM
Oct-14-23 07:20AM
Oct-07-23 07:43AM
Oct-06-23 08:31AM
Oct-04-23 06:30PM
Oct-02-23 08:00AM
Sep-26-23 03:07PM
Sep-16-23 08:00AM
Sep-14-23 01:12PM
07:05AM
06:35AM
Sep-12-23 12:46PM
Sep-11-23 05:04PM
10:41AM
Sep-08-23 04:30PM
(Yahoo Finance Video) -15.63%
02:33PM
01:28PM
12:01PM
10:17AM
09:12AM
09:03AM
07:23AM
06:50AM
Sep-07-23 10:49PM
05:11PM
04:05PM
Sep-06-23 06:33PM
(American City Business Journals)
05:14PM
12:42PM
06:45AM
Sep-05-23 10:57AM
10:03AM
Sep-04-23 12:23PM
Sep-03-23 07:55AM
07:55AM
Aug-31-23 04:05PM
08:34AM
Aug-23-23 11:12AM
Aug-11-23 06:32PM
RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lee Edward T SEE REMARKS Jan 04 '24 Sale 264.50 2,624 694,058 0 Jan 05 07:30 PM Belling Keith Director Dec 20 '23 Sale 305.57 500 152,783 5,423 Dec 22 09:00 PM Preston Jack M CHIEF FINANCIAL OFFICER Dec 15 '23 Option Exercise 61.30 33,399 2,047,359 33,400 Dec 18 09:15 PM Preston Jack M CHIEF FINANCIAL OFFICER Dec 15 '23 Sale 312.09 33,399 10,423,497 1 Dec 18 09:15 PM Chaya Eri SEE REMARKS Dec 14 '23 Option Exercise 61.30 50,000 3,065,000 50,000 Dec 18 09:15 PM Chaya Eri SEE REMARKS Dec 14 '23 Sale 290.00 50,000 14,500,000 0 Dec 18 09:15 PM ALBERINI CARLOS Director Sep 12 '23 Sale 310.42 25,000 7,760,462 21,916 Sep 13 09:00 PM Lee Edward T SEE REMARKS Jun 27 '23 Option Exercise 116.56 1,400 163,178 3,624 Jun 28 09:00 PM DEMILIO MARK S Director Jun 27 '23 Sale 305.24 2,000 610,473 14,480 Jun 28 09:00 PM Lee Edward T SEE REMARKS Jun 27 '23 Sale 300.00 1,400 420,000 2,624 Jun 28 09:00 PM Belling Keith Director Jun 14 '23 Sale 279.99 1,000 279,986 5,500 Jun 15 09:00 PM DEMILIO MARK S Director Jun 06 '23 Sale 267.35 2,000 534,700 16,480 Jun 07 09:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite